PHAR
USDPharming Group N.V. ADS each representing 10 ordinary shares
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$11.050
High
$11.140
Low
$11.050
Volume
0.00M
Company Fundamentals
Market Cap
767.1M
Industry
Biotechnology
Country
Netherlands
Trading Stats
Avg Volume
0.00M
Exchange
NGM
Currency
USD
52-Week Range
Related News
Pharming Group reports first quarter 2025 financial results and provides business update
First quarter 2025 total revenues increased by 42% to US$79.1 million, compared to the first quarter 2024 RUCONEST® revenue increased by 49% to US$68.6 million, compared to the first quarter 2024, reflecting
Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)
Leiden, the Netherlands, April 25, 2025: Pharming Group N.V. ("Pharming" or "the Company") (NASDAQ:PHAR) announces the following presentations by the Company or its collaborators at the 2025 Annual Meeting of the
Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS
For media and investors only Joenja® is the first and only medicine specifically for APDS to be reimbursed within the NHS Recommended for adult and pediatric patients 12 years of age and older with activated
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.